Indeed Snapshot

Track Blueprint Medicines reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 29th, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_100M_500M Cambridge, MA Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 29th, 2022 11:36AM Aug 29th, 2022 11:36AM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 28th, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_100M_500M Cambridge, MA Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 28th, 2022 04:35AM Aug 28th, 2022 04:35AM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 27th, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_100M_500M Cambridge, MA Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 27th, 2022 03:54AM Aug 27th, 2022 03:54AM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 25th, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_100M_500M Cambridge, MA Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 25th, 2022 08:34AM Aug 25th, 2022 08:34AM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 23rd, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_25M_100M 45 Sidney Street Cambridge, MA 02139 Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 23rd, 2022 10:27AM Aug 23rd, 2022 10:27AM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 21st, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_25M_100M 45 Sidney Street Cambridge, MA 02139 Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 21st, 2022 12:11PM Aug 21st, 2022 12:11PM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 20th, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_25M_100M 45 Sidney Street Cambridge, MA 02139 Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 20th, 2022 01:47PM Aug 20th, 2022 01:47PM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 19th, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_25M_100M 45 Sidney Street Cambridge, MA 02139 Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 19th, 2022 12:11PM Aug 19th, 2022 12:11PM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 18th, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_25M_100M 45 Sidney Street Cambridge, MA 02139 Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 18th, 2022 03:54AM Aug 18th, 2022 03:54AM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology
nasdaq:bpmc https://www.indeed.com/cmp/blueprint-medicines Aug 17th, 2022 12:00AM Open Blueprint Medicines Pharmaceutical & Biotechnology Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines directly to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy. With patients at the center of our mission, we aim to make real the promise of precision medicine to improve and extend life for as many people with cancer and blood disorders as possible. We know that in order to make a difference in their lives, we must create an environment where our employees—also known as the Blue Crew—can do their best work. Our culture of transparency, curiosity, and diversity pushes us to lead with integrity, act courageously, and draw upon a wide range of backgrounds and perspectives to make decisions. Ideas come from everywhere, from the C-suite to new hires, and each day we commit to approach one another with respect and trust. We care deeply about making a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/. Specialties: Precision therapy, targeted therapy, oncology, blood disorders, genomically defined cancers, systemic mastocytosis, lung cancer, cancer immunotherapy, rare diseases, hematology, molecular targeting, and drug design. RRv1_25M_100M 45 Sidney Street Cambridge, MA 02139 Kate Haviland 4.00 5.00 5.00 3.40 4.20 3.20 3.20 3.60 Aug 17th, 2022 09:33AM Aug 17th, 2022 09:33AM Blueprint Medicines Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.